Seres Therapeutics Inc (MCRB) Insider Trading
- $47,525,463.45
- $53,499,203.26
- Oct. 28, 2024
- Roger Pomerantz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 28, 2024 | CEO | 8,748 | $0.69 | Sell | $6,036.12 | |
Oct. 28, 2024 | Insider | 4,334 | $0.69 | Sell | $2,990.46 | |
Oct. 28, 2024 | EVP | 4,259 | $0.69 | Sell | $2,938.71 | |
Aug. 16, 2024 | Insider | 973 | $0.84 | Sell | $817.32 | |
Aug. 16, 2024 | EVP | 873 | $0.84 | Sell | $733.32 | |
Aug. 16, 2024 | CEO | 2,518 | $0.84 | Sell | $2,115.12 | |
Aug. 5, 2024 | Insider | 24,480 | $1.08 | Sell | $26,438.40 | |
May 15, 2024 | CEO | 2,435 | $0.94 | Sell | $2,288.90 | |
May 15, 2024 | EVP | 843 | $0.94 | Sell | $792.42 | |
May 15, 2024 | Insider | 939 | $0.94 | Sell | $882.66 | |
Feb. 16, 2024 | Insider | 3,374 | $1.08 | Sell | $3,643.92 | |
Feb. 16, 2024 | CEO | 11,549 | $1.08 | Sell | $12,472.92 | |
Feb. 16, 2024 | CFO | 3,939 | $1.08 | Sell | $4,254.12 | |
Oct. 30, 2023 | CEO | 8,552 | $1.35 | Sell | $11,545.20 | |
Oct. 30, 2023 | EVP | 4,156 | $1.35 | Sell | $5,610.60 | |
Oct. 30, 2023 | Insider | 2,904 | $1.35 | Sell | $3,920.40 | |
Oct. 30, 2023 | CFO | 4,066 | $1.35 | Sell | $5,489.10 | |
April 28, 2023 | Insider | 7,038 | $5.19 | Sell | $36,527.22 | |
Oct. 31, 2022 | Insider | 5,012 | $7.93 | Sell | $39,745.16 | |
July 5, 2022 | Major Shareholder | 8,738,243 | $3.15 | Buy | $27,525,465.45 | |
Nov. 22, 2019 | Insider | 3,400 | $3.91 | Sell | $13,294.00 | |
June 18, 2019 | Director | 8,888,888 | $2.25 | Buy | $19,999,998.00 | |
Jan. 28, 2019 | EVP | 5,471 | $5.75 | Sell | $31,458.25 | |
Jan. 28, 2019 | Insider | 4,378 | $5.75 | Sell | $25,173.50 | |
Dec. 17, 2018 | Insider | 14,282 | $6.39 | Sell | $91,261.98 | |
Oct. 15, 2018 | Insider | 14,279 | $5.94 | Sell | $84,817.26 | |
Sept. 17, 2018 | Insider | 42,837 | $7.64 | Sell | $327,274.68 | |
Sept. 6, 2018 | Insider | 12,518 | $9.10 | Sell | $113,913.80 | |
July 15, 2018 | EVP | 14,279 | $8.10 | Sell | $115,659.90 | |
July 10, 2018 | Insider | 32,336 | $9.12 | Sell | $294,904.32 | |
July 6, 2018 | CEO | 15,366 | $9.14 | Sell | $140,445.24 | |
June 29, 2018 | CEO | 4,496 | $9.10 | Sell | $40,913.60 | |
June 27, 2018 | CEO | 16,991 | $9.03 | Sell | $153,428.73 | |
June 25, 2018 | CEO | 26,752 | $9.21 | Sell | $246,385.92 | |
June 22, 2018 | CEO | 40,057 | $9.36 | Sell | $374,933.52 | |
June 20, 2018 | CEO | 26,492 | $9.33 | Sell | $247,170.36 | |
June 15, 2018 | Insider | 14,279 | $8.57 | Sell | $122,371.03 | |
May 9, 2018 | Insider | 233 | $9.00 | Sell | $2,097.00 | |
April 25, 2018 | Insider | 14,279 | $7.58 | Sell | $108,234.82 | |
Jan. 26, 2018 | Insider | 1,738 | $11.02 | Sell | $19,152.76 | |
Dec. 19, 2017 | Insider | 1,623 | $10.14 | Sell | $16,457.22 | |
Aug. 29, 2016 | Insider | 9,390 | $10.87 | Sell | $102,069.30 | |
July 28, 2016 | Insider | 4,156 | $35.18 | Sell | $146,208.08 | |
July 27, 2016 | Insider | 38,064 | $35.14 | Sell | $1,337,568.96 | |
July 25, 2016 | Insider | 9,390 | $34.18 | Sell | $320,950.20 | |
July 6, 2016 | CEO | 88,211 | $29.45 | Sell | $2,597,813.95 | |
July 1, 2016 | CEO | 56,789 | $29.81 | Sell | $1,692,880.09 | |
June 30, 2016 | CFO | 4,533 | $29.54 | Sell | $133,904.82 | |
June 28, 2016 | CFO | 5,001 | $28.28 | Sell | $141,428.28 | |
June 27, 2016 | EVP | 9,390 | $27.23 | Sell | $255,689.70 |
Insiders are both buying and selling Seres Therapeutics Inc stock.
The insider traders at Seres Therapeutics Inc are: Roger Pomerantz, John G Aunins, Eric D Shaff, David N Cook, Thomas Desrosier, Moltke Lisa Von, David Arkowitz, David S Ege, Michele Trucksis, Teresa L Young, Paula Cloghessy, Marcus Chapman, Ventures Fund 2007 L Flagship, Health Ltp Fund Ge Nutritional, and Noubar Afeyan
The most active insider trader at Seres Therapeutics Inc is Roger Pomerantz with 19 trades.
Ventures Fund 2007 L Flagship has sold the most Seres Therapeutics Inc stock with a total value of $55,200,000.00.
Health Ltp Fund Ge Nutritional has bought the most Seres Therapeutics Inc stock with a total value of $55,050,930.90.
The most recent insider trade for Seres Therapeutics Inc was on Oct. 28, 2024.
The single biggest insider buy for Seres Therapeutics Inc was from Health Ltp Fund Ge Nutritional with a total value of $27,525,465.45 on July 5, 2022.
The single biggest insider sell for Seres Therapeutics Inc was from Ventures Fund 2007 L Flagship with a total value of $27,600,000.00 on May 25, 2016.